Bulletin
Investor Alert

Sanofi

OTC: SNYNF

GO
/marketstate/country/us

Market closed

 --Quotes are delayed by 20 min

Mar 24, 2023, 3:12 p.m.

/zigman2/quotes/205505035/delayed

$

105.00

Change

+0.93 +0.89%

Volume

Volume 4,192

Quotes are delayed by 20 min

/zigman2/quotes/205505035/delayed

Previous close

$ 104.07

$ 105.00

Change

+0.93 +0.89%

Day low

Day high

$103.32

$105.00

Open

52 week low

52 week high

$73.31

$112.50

Open

Annual Financials for Sanofi

Fiscal year is February-January. All values EUR millions. 20222021202020192018 5-year trend
Sales/Revenue 43B37.76B36.04B36.13B34.46B
Cost of Goods Sold (COGS) incl. D&A 15.86B13.95B13.94B14.27B13.72B
COGS excluding D&A --10.67B--
Depreciation & Amortization Expense --3.27B--
Depreciation --1.45B--
Amortization of Intangibles --1.82B--
Gross Income 27.14B23.81B22.1B21.86B20.74B
20222021202020192018 5-year trend
SG&A Expense 17.12B15.15B14.83B15.78B15.66B
Research & Development --5.53B--
Other SG&A 10.41B9.46B9.3B9.77B9.77B
Other Operating Expense (4M)-(4M)(6M)(3M)
Unusual Expense 798M832M1.14B4.19B2.23B
EBIT after Unusual Expense 9.23B7.84B(1.14B)1.89B2.85B
Non Operating Income/Expense --8.07B--
Non-Operating Interest Income --37M--
Equity in Affiliates (Pretax) -----
Interest Expense 394M362M463M544M471M
Gross Interest Expense --474M--
Interest Capitalized --11M--
Pretax Income 10.42B7.8B13.78B2.82B4.41B
Income Tax 2.01B1.56B1.81B139M481M
Income Tax - Current Domestic --1.91B--
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic --(106M)--
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates 68M39M359M255M499M
Other After Tax Income (Expense) -----
Consolidated Net Income 8.48B6.28B12.33B2.94B4.42B
Minority Interest Expense 113M56M36M31M104M
Net Income 8.37B6.22B12.29B2.91B4.32B
Extraordinaries & Discontinued Operations ---(101M)(13M)
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries 8.37B6.22B12.29B2.81B4.31B
Preferred Dividends -----
Net Income Available to Common 8.37B6.22B12.29B2.91B4.32B
EPS (Basic) 6.694.979.812.333.46
Basic Shares Outstanding 1.25B1.25B1.25B1.25B1.25B
EPS (Diluted) 6.664.959.762.313.44
Diluted Shares Outstanding 1.26B1.26B1.26B1.26B1.26B
EBITDA 13.73B11.8B10.54B9.82B8.55B
Link to MarketWatch's Slice.